Omega Therapeutics, Inc. (OMGA) Misses Q1 EPS by 3c

Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $1.17 million.

For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight